Association of acylcarnitines with left ventricular remodeling in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

JAMA Cardiology

Volumn 3, Issue 3, 2018, Pages 242-246

  Elmariah, Sammy ^a,b   Farrell, Laurie A ^a,c   Furman, Deborah ^a   Lindman, Brian R ^d   Shi, Xu ^c   Morningstar, Jordan E ^c   Rhee, Eugene P ^a   Gerszten, Robert E ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; BRAIN NATRIURETIC PEPTIDE; CHOLINE; KYNURENINE; BIOLOGICAL MARKER; CARNITINE;

AGE; AGED; AORTIC STENOSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICULAR REMODELING; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; TERTIARY CARE CENTER; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; AORTIC VALVE STENOSIS; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETIC COMPLICATION; HEART STROKE VOLUME; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOMARKERS; CARNITINE; CHOLINE; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; KYNURENINE; MALE; RENAL INSUFFICIENCY, CHRONIC; STROKE VOLUME; TRANSCATHETER AORTIC VALVE REPLACEMENT; VENTRICULAR REMODELING;

EID: 85045921104     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.4873     Document Type: Article

References (12)

1. Weidemann F, Herrmann S, Stork S, et al. Impact ofmyocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009;120(7): 577-584.
2. Aasum E, Hafstad AD, Severson DL, Larsen TS. Age-dependent changes inmetabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes. 2003;52(2):434-441.
3. Nishimura RA, Otto CM, Bonow RO, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57-e185.
4. Ahmad T, Kelly JP, McGarrah RW, et al. Prognostic implications of long-chain acylcarnitines in heart failure and reversibility with mechanical circulatory support. J AmColl Cardiol. 2016;67(3): 291-299.
5. Hunter WG, Kelly JP, McGarrah RW III, et al. Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure. J AmHeart Assoc. 2016;5(8): e003190.
6. Elmariah S, Farrell LA, Daher M, et al. Metabolite profiles predict acute kidney injury and mortality in patients undergoing transcatheter aortic valve replacement. J AmHeart Assoc. 2016;5(3):e002712.
7. Lang RM, Bierig M, Devereux RB, et al; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108.
8. Levey AS, Coresh J, Greene T, et al; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-254.
9. Elmariah S, Palacios IF, McAndrew T, et al; PARTNER Investigators. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv. 2013;6(6):604-614.
10. Lindman BR, Stewart WJ, Pibarot P, et al. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. JACC Cardiovasc Interv. 2014;7(6):662-673.
11. Heather LC, Howell NJ, Emmanuel Y, et al. Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS One. 2011;6(10): e26326.
12. Lai L, Leone TC, Keller MP, et al. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: A multisystems approach. Circ Heart Fail. 2014;7(6):1022-1031.